Justin Manalac
Overview
Explore the profile of Justin Manalac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Wiredja D, Yang L, Bulterys P, Costales C, Roltgen K, et al.
Clin Chem
. 2021 Mar;
67(7):977-986.
PMID: 33720347
Background: Laboratory-based methods for SARS-CoV-2 antibody detection vary widely in performance. However, there are limited prospectively-collected data on assay performance, and minimal clinical information to guide interpretation of discrepant results....
2.
Roltgen K, Powell A, Wirz O, Stevens B, Hogan C, Najeeb J, et al.
Sci Immunol
. 2020 Dec;
5(54).
PMID: 33288645
SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, can neutralize the virus. It is, however, unknown which features of...
3.
Manalac J, Yee J, Calayag K, Nguyen L, Patel P, Zhou D, et al.
Clin Chim Acta
. 2020 Sep;
510:687-690.
PMID: 32910980
Background: We report our findings of test performance especially specificity of a fully automated Abbott Architect anti-SARS-CoV-2 CMIA IgG and Euroimmun anti-SARS-CoV-2 ELISA IgA/IgG in human plasma. Methods: We used...
4.
Roltgen K, Wirz O, Stevens B, Powell A, Hogan C, Najeeb J, et al.
medRxiv
. 2020 Aug;
PMID: 32839786
SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, could offer protective immunity, and may affect clinical outcomes of COVID-19...